可转移的元素改变基因表达,可能会影响卵巢癌中对西斯普拉丁治疗的反应
Daniela Moreira Mombach1, Rafael Luiz Vieira Mercuri2,3, Tiago Minuzzi Freire da Fontoura Gomes1
1Programa de Pós-Graduação em Genética e Biologia Molecular, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Carcinogenesis
|May 9, 2024
概括
像LINE1和Alu这样的可移植元素 (TEs) 在卵巢癌细胞中受到西斯普拉丁治疗的改变. 这些TEs影响癌症基因和途径,影响药物耐药性.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 西斯是一种基石化疗药物,但了解癌症的抵抗机制对于改善患者的治疗结果至关重要.
- 虽然研究了基因表达的变化,但可移植元素 (TEs) 在西斯普拉丁耐药性中的作用仍未得到充分研究.
研究的目的:
- 综合调查可移植元素 (TEs) 在抗西斯的卵巢癌中的表达和功能影响.
- 为了阐明TE如何影响宿主基因表达和细胞通路,以应对西斯治疗.
主要方法:
- 利用RNA-sequencing (RNA-seq) 和ATAC-sequencing (ATAC-seq) 来比较对西斯普拉丁敏感和耐药的卵巢癌细胞系.
- 进行了深入的生物信息学分析,以确定改变的TE及其与宿主基因的相互作用.
主要成果:
- 西斯普拉丁治疗显著改变了关键TEs (LINE1,Alu,内源性逆转录病毒) 在敏感和耐药细胞系中的表达.
- 发现TEs与宿主基因共同表达或形成嵌合体转录,可能调节与瘤相关的基因.
- 开发了一种模型,证明TE影响癌症基因和青反应关键的途径.
结论:
- 可转移元素的改变是西斯普拉丁治疗的重要后果,影响关键的癌症基因和途径.
- 考虑全谱的基因组元素,特别是TEs,对于全面了解癌症治疗反应和耐药性至关重要.
相关概念视频
02:13Overview of Transposition and Recombination
15.4K
Transposons make up a significant part of genomes of various organisms. Therefore, it is believed that transposition played a major evolutionary role in speciation by changing genome sizes and modifying gene expression patterns. For example, in bacteria, transposition can lead to conferring antibiotic resistance. Movement of transposable elements within the genetic pool of pathogenic bacteria can aid in transfer of antibiotic-resistant genetic elements. In eukaryotes, transposons can carry out...
15.4K
02:57DNA-only Transposons
14.5K
DNA-only transposons are called autonomous transposons since they code for the enzyme transposase that is required for the transposition mechanism. Insertion of transposons can alter gene functions in multiple ways. They can mutate the gene, alter gene expression by introducing a novel promoter or insulator sequence, introduce new splice sites, and change the mRNA transcripts produced, or remodel chromatin structure.
The donor site from where the transposon is excised is either degraded or...
The donor site from where the transposon is excised is either degraded or...
14.5K
03:18Non-LTR Retrotransposons
11.5K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.5K
02:57piRNA - Piwi-interacting RNAs
6.8K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
6.8K
01:06Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K